Testosterone and cardiometabolic risk in the general population – the impact of measurement method on risk associations

a comparative study between immunoassay and mass spectrometry

Haring, Robin
Baumeister, Sebastian E
Nauck, Matthias
Völzke, Henry
Keevil, Brian G
Brabant, Georg
Wallaschofski, Henri

Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Greifswald, Germany
DZHK (German Centre for Cardiovascular Research), partner site, University Medicine Greifswald, Greifswald, Germany
Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany
Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Greifswald, Germany
DZHK (German Centre for Cardiovascular Research), partner site, University Medicine Greifswald, Greifswald, Germany
DZHK (German Centre for Cardiovascular Research), partner site, University Medicine Greifswald, Greifswald, Germany
Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany
Department of Clinical Chemistry, University Hospital South Manchester, Manchester, UK
Department of Clinical Chemistry, University Hospital South Manchester, Manchester, UK
Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Greifswald, Germany
DZHK (German Centre for Cardiovascular Research), partner site, University Medicine Greifswald, Greifswald, Germany

(Correspondence should be addressed to R Haring at Institute of Clinical Chemistry and Laboratory Medicine; Email: [email protected])

Received March 19, 2013

Received in revised form July 09, 2013

Accepted July 29, 2013

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)

European Journal of Endocrinology 169(4):p 463-470, October 2013. | DOI: 10.1530/EJE-13-0222